{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T23:00:52Z","timestamp":1785798052215,"version":"3.56.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>To investigate cancer disparities between lean (BMI\u2009&lt;\u200925\u00a0kg\/m\u00b2; &lt; 23\u00a0kg\/m\u00b2 for Asians) and non-lean metabolic dysfunction-associated steatohepatitis (MASH) by analyzing the prevalence of the 18 most common cancers in a large U.S. cohort.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective cohort study utilized the National Inpatient Sample (2016\u20132020) with weighted data to project findings to the general population. Patients were categorized as lean or non-lean based on BMI during hospitalization, excluding alternative etiologies via validated algorithms. Outcomes included composite cancer prevalence (primary) and individual cancer prevalence (secondary). Multivariable logistic regression was applied to assess differences.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 34,955,252 U.S. hospitalizations, 539,275 patients had MASH (mean age: 64 years for lean vs. 58.8 years for non-lean; &gt;60% female). Lean MASH hospitalizations had higher odds of lung (aOR 1.76, CI 1.33\u20132.10, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), colon (aOR 1.23, CI 1.02\u20131.48, <jats:italic>P<\/jats:italic>\u2009=\u20090.027), kidney (aOR 1.27, CI 1.10\u20131.44, <jats:italic>P<\/jats:italic>\u2009=\u20090.001), liver (aOR 1.21, CI 1.12\u20131.31, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001), and cervical cancers (aOR 3.25, CI 1.07\u20139.86, <jats:italic>P<\/jats:italic>\u2009=\u20090.037), as well as non-Hodgkin\u2019s lymphoma (aOR 1.28, CI 1.08\u20131.51, <jats:italic>P<\/jats:italic>\u2009=\u20090.004), but lower odds of endometrial cancer (aOR 0.35, CI 0.25\u20130.50, <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Lean MASH hospitalizations are linked to higher odds of several cancers despite lower BMI, underscoring the need for a nuanced understanding of cancer risks in MASH. BMI alone may not fully capture oncologic risk in this population.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12876-025-04187-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:54:20Z","timestamp":1758880460000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cancer disparities in lean vs. non-lean MASH: insight from a national inpatient sample"],"prefix":"10.1186","volume":"25","author":[{"given":"Chukwunonso","family":"Ezeani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chidiebele","family":"Omaliko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Protiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan A.","family":"Al-Ajlouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyanprakash","family":"Ketwaroo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Njei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"6","key":"4187_CR1","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V, Francque SM, Sanyal AJ, Kanwal F, et al. A multisociety delphi consensus statement on new fatty liver disease nomenclature. Hepatology. 2023;78(6):1966\u201386.","journal-title":"Hepatology"},{"issue":"4","key":"4187_CR2","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","volume":"18","author":"DQ Huang","year":"2021","unstructured":"Huang DQ, El-Serag HB, Loomba R. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2021;18(4):223\u201338.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"6","key":"4187_CR3","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1002\/hep.30251","volume":"69","author":"Z Younossi","year":"2019","unstructured":"Younossi Z, Tacke F, Arrese M, Chander Sharma B, Mostafa I, Bugianesi E, et al. Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Hepatology. 2019;69(6):2672\u201382.","journal-title":"Hepatology"},{"issue":"1","key":"4187_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease\u2014meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73\u201384.","journal-title":"Hepatology"},{"issue":"12","key":"4187_CR5","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1016\/j.cmet.2023.10.018","volume":"35","author":"C Pan","year":"2023","unstructured":"Pan C, Liu J, Gao Y, Yang M, Hu H, Liu C, et al. Hepatocyte CHRNA4 mediates the MASH-promotive effects of immune cell-produced acetylcholine and smoking exposure in mice and humans. Cell Metabol. 2023;35(12):2231\u201349. e7.","journal-title":"Cell Metabol"},{"issue":"44","key":"4187_CR6","doi-asserted-by":"publisher","first-page":"7597","DOI":"10.3748\/wjg.v27.i44.7597","volume":"27","author":"A Tringali","year":"2021","unstructured":"Tringali A, Costa D, Fugazza A, Colombo M, Khalaf K, Repici A, et al. Endoscopic management of difficult common bile duct stones: where are we now? A comprehensive review. World J Gastroenterol. 2021;27(44):7597\u2013611.","journal-title":"World J Gastroenterol"},{"issue":"5","key":"4187_CR7","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cgh.2011.01.023","volume":"9","author":"K Yasui","year":"2011","unstructured":"Yasui K, Hashimoto E, Komorizono Y, Koike K, Arii S, Imai Y, et al. Characteristics of patients with nonalcoholic steatohepatitis who develop hepatocellular carcinoma. Clin Gastroenterol Hepatol. 2011;9(5):428\u201333.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4187_CR8","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.cell.2009.12.052","volume":"140","author":"EJ Park","year":"2010","unstructured":"Park EJ, Lee JH, Yu G-Y, He G, Ali SR, Holzer RG, et al. Dietary and genetic obesity promote liver inflammation and tumorigenesis by enhancing IL-6 and TNF expression. Cell. 2010;140(2):197\u2013208.","journal-title":"Cell"},{"key":"4187_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154170","volume":"111","author":"A Mantovani","year":"2020","unstructured":"Mantovani A, Scorletti E, Mosca A, Alisi A, Byrne CD, Targher G. Complications, morbidity and mortality of nonalcoholic fatty liver disease. Metabolism. 2020;111: 154170.","journal-title":"Metabolism"},{"issue":"6","key":"4187_CR10","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.jhep.2019.08.018","volume":"71","author":"AM Allen","year":"2019","unstructured":"Allen AM, Hicks SB, Mara KC, Larson JJ, Therneau TM. The risk of incident extrahepatic cancers is higher in non-alcoholic fatty liver disease than obesity - a longitudinal cohort study. J Hepatol. 2019;71(6):1229\u201336.","journal-title":"J Hepatol"},{"issue":"12","key":"4187_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1001\/jama.2020.2298","volume":"323","author":"AC Sheka","year":"2020","unstructured":"Sheka AC, Adeyi O, Thompson J, Hameed B, Crawford PA, Ikramuddin S. Nonalcoholic Steatohepatitis. JAMA. 2020;323(12):1175.","journal-title":"JAMA"},{"key":"4187_CR12","unstructured":"Farquhar M. AHRQ quality indicators. Patient safety and quality: an evidence-based handbook for nurses. 2008."},{"issue":"4","key":"4187_CR13","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1213\/ANE.0000000000006107","volume":"135","author":"GW Williams","year":"2022","unstructured":"Williams GW, Rihani R, Bui A. HCUP databases May be helpful in limiting Bias. Anesth Analgesia. 2022;135(4):e21\u2013e.","journal-title":"Anesth Analgesia"},{"issue":"5","key":"4187_CR14","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.annemergmed.2014.09.014","volume":"64","author":"R Mutter","year":"2014","unstructured":"Mutter R, Stocks C. Using healthcare cost and utilization project (HCUP) data for emergency medicine research. Ann Emerg Med. 2014;64(5):458\u201360.","journal-title":"Ann Emerg Med"},{"key":"4187_CR15","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.ejim.2023.11.005","volume":"122","author":"V Lekakis","year":"2024","unstructured":"Lekakis V, Papatheodoridis GV. Natural history of metabolic dysfunction-associated steatotic liver disease. Eur J Intern Med. 2024;122:3\u201310.","journal-title":"Eur J Intern Med"},{"issue":"7","key":"4187_CR16","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","volume":"70","author":"TG Simon","year":"2021","unstructured":"Simon TG, Roelstraete B, Khalili H, Hagstr\u00f6m H, Ludvigsson JF. Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut. 2021;70(7):1375\u201382.","journal-title":"Gut"},{"issue":"1","key":"4187_CR17","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.jhep.2017.09.012","volume":"68","author":"G-A Kim","year":"2018","unstructured":"Kim G-A, Lee HC, Choe J, Kim M-J, Lee MJ, Chang H-S, et al. Association between non-alcoholic fatty liver disease and cancer incidence rate. J Hepatol. 2018;68(1):140\u20136.","journal-title":"J Hepatol"},{"key":"4187_CR18","doi-asserted-by":"publisher","first-page":"100809","DOI":"10.1016\/j.neo.2022.100809","volume":"30","author":"F Petrelli","year":"2022","unstructured":"Petrelli F, Manara M, Colombo S, De Santi G, Ghidini M, Mariani M, et al. Hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis: HCC and steatosis or steatohepatitis. Neoplasia. 2022;30:100809.","journal-title":"Neoplasia"},{"issue":"1","key":"4187_CR19","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.5301\/JBM.5000047","volume":"29","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Liu H, Yang S, Zhang J, Qian L, Chen X. Overweight, obesity and endometrial Cancer risk: results from a systematic review and Meta-Analysis. Int J Biol Mark. 2014;29(1):e21\u20139.","journal-title":"Int J Biol Mark"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04187-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04187-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04187-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:54:22Z","timestamp":1758880462000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04187-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":19,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4187"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04187-1","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No IRB was required for this study, due to use of national de-identified data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"N\/A.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"659"}}